Contents

Search

Chlamydia trachomatis+Neisseria gonorrhoeae point of care test

Point of care test. Indications: - evaluation of Chlamydia trachomatis Neisseria gonorrhoeae infection Method: - point of care test, results in 30 minutes - processes a single-use cartridge - samples collected using female vaginal swabs & male urine specimens Clinical significance: - allows for single visit diagosis & treatmnent of Chlamydia & gonorrhea Notes: - Binx Health IO CT/NG Assay FDA-approved

Related

Chlamydia trachomatis Chlamydia trachomatis + Neisseria gonorrhoeae DNA (GenProbe, Amplicor) Chlamydia trachomatis+Neisseria gonorrhoeae rRNA Neisseria gonorrhoeae (gonococcus, GC)

General

point of care test

References

  1. Van Der Pol B, Taylor SN, Mena L et al Evaluation of the Performance of a Point-of-Care Test for Chlamydia and Gonorrhea. JAMA Netw Open. 2020;3(5):e204819. PMID: 32407506 Free Article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765941
  2. FDA News Release March 30, 2021 FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings. https://www.fda.gov/news-events/press-announcements/fda-allows-first-point-care-chlamydia-and-gonorrhea-test-be-used-more-near-patient-care-settings